ADAR1 Capital Management »

Ngm Biopharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Ngm Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ngm Biopharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ngm Biopharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 817k 1.59

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Ngm Biopharmaceuticals

Column Group
BlackRock
Vanguard Group
StepStone
Euclidean Capital
Geode Capital Management
Trium Capital
ADAR1 Capital Management
Two Sigma Advisers
Northern Trust
Balyasny Asset Management
Federated Investors
Citadel Advisors
Charles Schwab Investment Management
Goldman Sachs Group

View all funds holding Ngm Biopharmaceuticals